6.
Sullivan J, Schoch K, Spillmann R, Shashi V
. Exome/Genome Sequencing in Undiagnosed Syndromes. Annu Rev Med. 2023; 74:489-502.
PMC: 10483513.
DOI: 10.1146/annurev-med-042921-110721.
View
7.
Cardinali P, Migliorini L, Rania N
. The Caregiving Experiences of Fathers and Mothers of Children With Rare Diseases in Italy: Challenges and Social Support Perceptions. Front Psychol. 2019; 10:1780.
PMC: 6690318.
DOI: 10.3389/fpsyg.2019.01780.
View
8.
Lamperti C, Fabbri G, Vercelli L, DAmico R, Frusciante R, Bonifazi E
. A standardized clinical evaluation of patients affected by facioscapulohumeral muscular dystrophy: The FSHD clinical score. Muscle Nerve. 2010; 42(2):213-7.
DOI: 10.1002/mus.21671.
View
9.
Megalizzi D, Trastulli G, Caputo V, Colantoni L, Caltagirone C, Strafella C
. Epigenetic profiling of the D4Z4 locus: Optimization of the protocol for studying DNA methylation at single CpG site level. Electrophoresis. 2023; 44(19-20):1588-1594.
DOI: 10.1002/elps.202300058.
View
10.
Roggenbuck J, Fong J
. Genetic Testing for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia: Impact on Clinical Management. Clin Lab Med. 2020; 40(3):271-287.
DOI: 10.1016/j.cll.2020.05.002.
View
11.
Testa F, Carreno E, van den Born L, Melillo P, Perea-Romero I, Di Iorio V
. Multicentric Longitudinal Prospective Study in a European Cohort of MYO7A Patients: Disease Course and Implications for Gene Therapy. Invest Ophthalmol Vis Sci. 2024; 65(6):25.
PMC: 11185270.
DOI: 10.1167/iovs.65.6.25.
View
12.
Benito-Lozano J, Lopez-Villalba B, Arias-Merino G, Posada de la Paz M, Alonso-Ferreira V
. Diagnostic delay in rare diseases: data from the Spanish rare diseases patient registry. Orphanet J Rare Dis. 2022; 17(1):418.
PMC: 9670379.
DOI: 10.1186/s13023-022-02530-3.
View
13.
Mah J, Korngut L, Fiest K, Dykeman J, Day L, Pringsheim T
. A Systematic Review and Meta-analysis on the Epidemiology of the Muscular Dystrophies. Can J Neurol Sci. 2016; 43(1):163-77.
DOI: 10.1017/cjn.2015.311.
View
14.
Rillig F, Gruters A, Schramm C, Krude H
. The Interdisciplinary Diagnosis of Rare Diseases. Dtsch Arztebl Int. 2022; 119(27-28):469-475.
PMC: 9664985.
DOI: 10.3238/arztebl.m2022.0219.
View
15.
Ramoni R, Mulvihill J, Adams D, Allard P, Ashley E, Bernstein J
. The Undiagnosed Diseases Network: Accelerating Discovery about Health and Disease. Am J Hum Genet. 2017; 100(2):185-192.
PMC: 5294757.
DOI: 10.1016/j.ajhg.2017.01.006.
View
16.
Weil D, Kussel P, Blanchard S, Levy G, Levi-Acobas F, Drira M
. The autosomal recessive isolated deafness, DFNB2, and the Usher 1B syndrome are allelic defects of the myosin-VIIA gene. Nat Genet. 1997; 16(2):191-3.
DOI: 10.1038/ng0697-191.
View
17.
Pinto D, Delaby E, Merico D, Barbosa M, Merikangas A, Klei L
. Convergence of genes and cellular pathways dysregulated in autism spectrum disorders. Am J Hum Genet. 2014; 94(5):677-94.
PMC: 4067558.
DOI: 10.1016/j.ajhg.2014.03.018.
View
18.
Delourme M, Charlene C, Gerard L, Ganne B, Perrin P, Vovan C
. Complex 4q35 and 10q26 Rearrangements: A Challenge for Molecular Diagnosis of Patients With Facioscapulohumeral Dystrophy. Neurol Genet. 2023; 9(3):e200076.
PMC: 10188231.
DOI: 10.1212/NXG.0000000000200076.
View
19.
Ruggiero L, Mele F, Manganelli F, Bruzzese D, Ricci G, Vercelli L
. Phenotypic Variability Among Patients With D4Z4 Reduced Allele Facioscapulohumeral Muscular Dystrophy. JAMA Netw Open. 2020; 3(5):e204040.
PMC: 7195625.
DOI: 10.1001/jamanetworkopen.2020.4040.
View
20.
Deenen J, Arnts H, van der Maarel S, Padberg G, Verschuuren J, Bakker E
. Population-based incidence and prevalence of facioscapulohumeral dystrophy. Neurology. 2014; 83(12):1056-9.
PMC: 4166358.
DOI: 10.1212/WNL.0000000000000797.
View